Journal
CLINICS IN LIVER DISEASE
Volume 21, Issue 4, Pages 793-813Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2017.06.006
Keywords
Liver transplantation; Immunosuppression; Outcomes; Prophylaxis; Screening
Categories
Funding
- Novartis
- Abbvie
Ask authors/readers for more resources
The focus in liver transplantation in the next 10 years will likely change from preventing viral disease recurrence to minimizing the toll of rejection and fatty liver disease, minimizing the complications from immunosuppression with withdrawal strategies, and more optimal management of long-term risks, such as malignancy, cardiovascular disease, and renal failure. In addition, now that short-term results (< 1 year) have improved significantly, there will be a shift toward improving long-term patient and graft survival, as well as a focus on primary care preventive strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available